Intellia Therapeutics Aktie
8,72
EUR
+0,02
EUR
+0,18
%
9,40
USD
-0,07
USD
-0,74
%
Werbung
Intellia Therapeutics Aktie Analyse
02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung